Nexpoint Asset Management’s Verona Pharma VRNA Stock Holding History

Nexpoint Asset Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-584,601	Closed	-$62.4M	–	124
2025 Q3	$62.4M	Buy	+584,601	New	+$61M	5.42%	4

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Nexpoint Asset Management's VRNA Position: Q4 2025 in Review

Nexpoint Asset Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 584,601 shares — an estimated $62.4M sold.

Nexpoint Asset Management first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $62.4M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Nexpoint Asset Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Nexpoint Asset Management sold 584,601 Verona Pharma shares in Q4 2025, an estimated $62.4M.
Nexpoint Asset Management first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
Nexpoint Asset Management's Verona Pharma position peaked at $62.4M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Nexpoint Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.